ADHD Patch

The FDA has recently approved the first patch called Daytrana to treat ADHD. This patch contains the stimulant methylphenidate (the same active ingredient in Ritalin) and is designed to be worn for 9 hours. The FDA recommends it's use only when taking the oral medication by mouth has been a hardship.

Nearly 3.3 million Americans age 19 and younger used an ADHD drug last year, according to Medco Health Solutions Inc., a prescription drug benefit program manager.

A panel of outside experts recently recommended to the FDA that the drugs bear labels that caution users in plain language about possible dangers, including stroke and hallucinations. Earlier, another FDA panel recommended that the medicines include so-called "black-box" warnings. That is the strongest warning a prescription drug can bear.

Comments

Popular posts from this blog

Interface Consultation Services - Update

Interface Consultation Services - Update (Hiring Part - Time)